Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) rose sharply in pre-market trading after the company disclosed that the FDA has lifted the clinical hold on the pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

Rocket Pharmaceuticals shares jumped 15.8% to $3.37 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• NovaBay Pharmaceuticals, Inc. (NYSE:NBY) climbed 64.2% to $0.9950 in pre-market trading following the announcement of major investment and leadership changes that could prevent the company's liquidation.
• Propanc Biopharma, Inc. (NASDAQ:PPCB) shares gained 37.8% to $5.06 in pre-market trading after falling 37% on Tuesday.
• ScanTech AI Systems Inc. (NASDAQ:STAI) gained 36.4% to $0.6398 in pre-market trading after the company announced a service collaboration with Curie Technologies to integrate Curie Software Platform into SENTINEL CT offering to enhance service delivery and customer success.
• Shineco, Inc. (NASDAQ:SISI) gained 28.3% to $6.35 in pre-market trading as the company announced the execution of a “Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement” with blockchain infrastructure provider Plus Me Limited.
• CNFinance Holdings Limited (NYSE:CNF) rose 20.4% to $0.5899 in pre-market trading after declining 8% on Tuesday.
• Global Engine Group Holding Limited (NASDAQ:GLE) gained 15.3% to $0.8174 in pre-market trading.
• Aspen Insurance Holdings Limited (NYSE:AHL) rose 11.9% to $30.97 in pre-market trading.
• Hertz Global Holdings, Inc. (NASDAQ:HTZ) gained 9.8% to $5.71 in pre-market trading. Hertz Global recently reported better-than-expected Q2 financial results.
• Soligenix, Inc. (NASDAQ:SNGX) jumped 7% to $3.94 in pre-market trading after dipping 25% on Tuesday.

Losers

• James Hardie Industries plc (NYSE:JHX) shares tumbled 27% to $20.72 in pre-market trading r following worse-than-expected quarterly financial results.
• Cytosorbents Corporation (NASDAQ:CTSO) dipped 25.7% to $0.8022 in pre-market trading after the company issued updates on the regulatory status of its appeal with the FDA for De Novo market authorization of DrugSorb™-ATR.
• Color Star Technology Co., Ltd. (NASDAQ:ADD) fell 25.3% to $0.0929 in pre-market trading. Color Star Technology announced corporate name change and 25-for-1 reverse share split.
• PainReform Ltd. (NASDAQ:PRFX) fell 24.2% to $1.7990 in pre-market trading after jumping 77% on Tuesday.
• La-Z-Boy Incorporated (NYSE:LZB) fell 22.2% to $30.40 in pre-market trading as the company reported weaker-than-expected financial results for the first quarter of fiscal 2026.
• Celldex Therapeutics, Inc. (NASDAQ:CLDX) fell 16.7% to $20.00 in pre-market trading. The company reported Phase 2 topline results for Barzolvolimab in Eosinophilic Esophagitis.
• Gaxos.ai Inc. (NASDAQ:GXAI) shares dipped 15.1% to $1.75 in the pre-market trading session. Gaxos shares jumped 87% on Tuesday after the company announced the launch of its Art-Gen.AI video creation platform.
• Alcon Inc. (NYSE:ALC) declined 12.3% to $79.06 in pre-market trading after the company cut its FY25 sales guidance.
• Target Corporation (NYSE:TGT) dipped 9.8% to $95.00 in pre-market trading following the company’s second-quarter earnings report. The company reaffirmed 2025 outlook and announced the appointment of Michael Fiddelke as CEO.
• The Estée Lauder Companies Inc. (NYSE:EL) fell 8.5% to $82.34 in pre-market trading after reporting quarterly results.

Now Read This:

• Top 2 Financial Stocks You May Want To Dump In Q3

Photo via Shutterstock